Fairvalue-Calculator Fairvalue-Calculator
EN DE

BioScience Health Innovations, Inc (BHIC) Fair Value & Analysis

Healthcare · US · Market cap $47.7M

Price$4.09
Fair Value$0.9600
Upside-76.5%
Quality91/100
Evidence: High Range $0.5600 – $1.20

Fair value as of: Jun 24, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

BioScience Health Innovations, Inc (BHIC) currently trades at $4.09, while our model-based Fair Value estimate is $0.9600 — implying the stock looks roughly 76.5% overvalued today. We read business quality at 91/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).

About the company

BioScience Health Innovations, Inc. operates as a health and wellness innovation company focuses on mitochondrial health science, advanced peptide delivery, and metabolic care in the United States. It offers nutritional supplements, peptides, and bioactive compounds through its core technology Mineral Oxide Delivery System, as well as provides Oracle NetSuite, an accounting and financial reporting system. The company also provides services, including testosterone and hormonal Optimization, NAD+ and cellular health, and platform licensing and peptide delivery. It sells its products through Amazon platform; and direct-to-consumer. The company was formerly known as Nowtransit Inc and changed its name to BioScience Health Innovations, Inc. in February 2025. BioScience Health Innovations, Inc. is based in Bluffdale, Utah.

Open the full interactive analysis →

Similar stocks

JD Health International Inc (JDHIF) +404% Alibaba Health Information Technology Limited (ALBBY) -20% Raia Drogasil S.A (RADL3) -8% Yifeng Pharmacy Chain Co (603939) +5% Clicks Group (CLCGY) +23% Sugi Holdings (SGIPF) +295%

Frequently asked questions

Is BioScience Health Innovations, Inc (BHIC) undervalued?
As of Jun 24, 2026, our model estimates a fair value of $0.9600 versus a price of $4.09 — about −77% (overvalued). Model-based estimate, not financial advice.
What is the fair value of BHIC?
Our 21-model fair value for BioScience Health Innovations, Inc is $0.9600 (as of Jun 24, 2026), built from audited fundamentals. The current price is $4.09.
What is the quality score of BHIC?
BioScience Health Innovations, Inc has a Quality Score of 91/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.